Polymyxins Nebulization over Intravenous Injection: Pharmacokinetics and Pharmacodynamics-Based Therapeutic Evaluation (original) (raw)
Pharmacokinetics and pharmacodynamics of ‘old’ polymyxins: what is new?
Phillip Bergen
Diagnostic Microbiology and Infectious Disease, 2012
View PDFchevron_right
Polymyxin Combinations: Pharmacokinetics and Pharmacodynamics for Rationale Use
Alan Forrest, Zackery Bulman
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2015
View PDFchevron_right
Aerosolized Polymyxin-E For The Treatment Of Multidrug Resistant Respiratory Tract Infections
IOSR Journals
View PDFchevron_right
Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet?
Phillip Bergen
Carolina Digital Repository (University of North Carolina at Chapel Hill), 2016
View PDFchevron_right
Colistin: The Revival of Polymyxins for the Management of Multidrug-Resistant Gram-Negative Bacterial Infections
Louis Saravolatz
Clinical Infectious Diseases, 2005
View PDFchevron_right
International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infecti...
ilias Karaiskos
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
View PDFchevron_right
Comparative Pharmacokinetic Profiling of Different Polymyxin B Components
Pooja Manchandani
View PDFchevron_right
Pharmacokinetic/Pharmacodynamic Based Breakpoints of Polymyxin B for Bloodstream Infections Caused by Multidrug-Resistant Gram-Negative Pathogens
Phillip Bergen
Frontiers in Pharmacology, 2022
View PDFchevron_right
Pharmacokinetics/pharmacodynamics of systemically administered polymyxin B against Klebsiella pneumoniae in mouse thigh and lung infection models
Cornelia Landersdorfer
The Journal of antimicrobial chemotherapy, 2017
View PDFchevron_right
Therapeutic Specification of the Last Resort Polymyxins: An Intelligent Approach
jahidul hasan
International Journal of Infection
View PDFchevron_right
Polymyxins: a review of the current status including recent developments
Andrea Kwa
Annals of the Academy of Medicine, Singapore, 2008
View PDFchevron_right
Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus
David Paterson
The Lancet Infectious Diseases, 2015
View PDFchevron_right
Intravenous polymyxin B for the treatment of nosocomial pneumonia caused by multidrug-resistant Pseudomonas aeruginosa
Henrique Campos
International Journal of Antimicrobial Agents, 2007
View PDFchevron_right
Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens
T. Behle
Clinical Infectious Diseases, 2013
View PDFchevron_right
Polymyxins combined with other antibiotics for the treatment of multi-resistant Gram negative bacteria: review of the literature
Maria Helena Rigatto
Principles and Practice of Clinical Research
View PDFchevron_right
Polymyxins: Antimicrobial susceptibility concerns and therapeutic options
balaji veeraraghavan
Indian Journal of Medical Microbiology, 2011
View PDFchevron_right
Characterization of Polymyxin B Biodistribution and Disposition in an Animal Model
Pooja Manchandani, Jian Zhou
View PDFchevron_right
Global survey of polymyxin use: A call for international guidelines
Heiman Wertheim
Journal of Global Antimicrobial Resistance, 2013
View PDFchevron_right
Evaluation of susceptibility testing methods for polymyxin
babita gupta
International Journal of Infectious Diseases, 2010
View PDFchevron_right
Polymyxin Monotherapy vs. Combination Therapy for the Treatment of Multidrug-resistant Infections: A Systematic Review and Meta-analysis
samir samal
Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine, 2021
View PDFchevron_right
Polymyxin B and colistimethate are comparable as to efficacy and renal toxicity
Gladys Prado
Diagnostic Microbiology and Infectious Disease, 2009
View PDFchevron_right
Dosing and pharmacokinetics of polymyxin B in renal insufficiency
Pooja Manchandani
Antimicrobial Agents and Chemotherapy, 2016
View PDFchevron_right
Polymyxin Acute Kidney Injury: Dosing and Other Strategies to Reduce Toxicity
Maria Helena Rigatto
Antibiotics
View PDFchevron_right
An alternative strategy for combination therapy: Interactions between polymyxin B and non-antibiotics
Wendy Kloezen
International Journal of Antimicrobial Agents, 2018
View PDFchevron_right
Optimizing Polymyxin Combinations Against Resistant Gram-Negative Bacteria
Cornelia Landersdorfer
Infectious diseases and therapy, 2015
View PDFchevron_right
The Clinical Efficacy of Polymyxin Monotherapy versus Non-validated Polymyxin Combination Therapy versus Validated Polymyxin Combination Therapy in Extensively Drug-Resistant Gram-Negative Bacilli Infections
Andrea Kwa
Antimicrobial agents and chemotherapy, 2016
View PDFchevron_right